K awasaki disease (KD) is an acute febrile illness characterized by systemic vasculitis of unknown cause that may lead to acquired heart disease that predominantly affects children <5 years of age, with a male:female ratio of 1.5:1.
1-10 KD, if untreated leads to coronary artery abnormalities in ≤30% of children and is the leading cause of acquired heart disease in children in the United States. 8 The pathogenesis of KD remains unknown despite 40 years of intensive studies, although the current paradigm is that KD is triggered by an infectious agent that elicits an inflammatory response directed at cardiovascular tissues in genetically susceptible hosts. 2, 3, 4, 11, 12 Treatment with high dose of intravenous immunoglobulin (IVIG) resolves inflammation and reduces the occurrence of coronary abnormalities, predominantly coronary artery aneurysms from 25% to 30% down to 5% to 7%. [13] [14] [15] Currently, studies from the United States report an aneurysm rate of ≈5%, despite IVIG therapy. 10 Importantly, up to 20% of patients with KD are IVIG resistant and do not respond to the initial IVIG dose and thus have a particularly high risk of developing coronary artery aneurysm.
complications. 17 Although IVIG reduces the rate of coronary artery aneurysm and the morbidity and mortality associated with KD, lack of a specific pathogenic agent and incomplete understanding of the molecular mechanisms mediating the cardiovascular pathology of KD have hampered the development of targeted and more effective treatment options. The limited availability of tissue samples from patients with KD has significantly impeded our progress in understanding the pathogenesis of the disease, making the availability of a relevant animal model extremely valuable.
Importantly, a well-described and well-accepted mouse model of KD vasculitis and coronary arteritis closely mimics the important histological as well as immune-pathological features of the cardiovascular lesions (ie, coronary arteritis, aortitis, myocarditis, aneurysms, including luminal myofibroblast proliferation and scarring and stenosis in the coronary arteries). [18] [19] [20] [21] [22] This mouse model (Lactobacillus casei cell-wall extract [LCWE]-induced KD vasculitis) reliably predicts efficacy of treatment options in children with KD. 18, 19, 21, 23, 24 A single intraperitoneal injection of LCWE reproducibly induces aortitis and proximal coronary arteritis (including epicardial coronary arteritis) that are histopathologically similar to the coronary arteritis observed in human KD. 18 Although no animal model can fully mimic human disease, the LCWE-induced KD mouse model, has been accepted by many in the Kawasaki research community, as a reliable experimental model with the goal to provide novel insights that can be tested in children. The translational value of this animal model has recently been shown again when discovery for the role of IL-1 signaling in the development of the coronary arteritis/stenosis and myocarditis associated with this KD mouse model 25 has led to successful treatment of several IVIG-resistant KD cases with the IL-1 R antagonist (Anakinra) 26, 27 and most importantly to the initiation of 2 phase II clinical trials with Anakinra in patients with KD.
KD not only causes vessel inflammation in small and medium size arteries with a distinct predilection for the coronary arteries but is also associated with dilation and aneurysms in almost any systemic arteries, including axillary, subclavian, brachial, renal and iliac arteries as well as the abdominal aortic aneurysm (AAA). [28] [29] [30] [31] The presence of systemic aortic aneurysms frequently indicates acute severe vasculitis and increases the likelihood of severe cardiac sequelae. 32 However, although coronary artery abnormalities, including aneurysms, have been well evaluated, investigations into inflammation at other systemic arterial sites in patients with KD are relatively limited. In addition, it is still unknown whether these aortic dilatations and aneurysms are caused by a process similar to the coronary arteritis in patients with KD. Progression to excessive remodeling and vasculopathies, cardiovascular diseases, and early death among survivors of childhood KD have been reported with increasing frequency. [33] [34] [35] It is now accepted that systemic vascular inflammation in patients with KD in childhood may persist beyond the acute stages and lead to an increased risk of subsequent cardiovascular diseases.
IL-1β plays a critical role in broad spectrum of diseases, including chronic inflammatory diseases such as rheumatoid arthritis, metabolic syndrome, diabetes mellitus, atherosclerosis, and more recently it was linked to KD vasculitis. 25, [36] [37] [38] [39] [40] [41] IL-1α also plays a critical role in chronic inflammation and studies suggest that IL-1α can regulate IL-1β secretion. 37, [42] [43] [44] We have shown the key role of Toll-like receptor 2 and IL-1R via MyD88 signaling in coronary arteritis and aortic root vasculitis in this KD mouse model. 25, 45 IL-1 receptor antagonist (Anakinra) given either prophylactically or ≤3 days after LCWE injection efficiently prevents the development of KD vasculitis, coronary artery lesions, and myocarditis in mice. 25 In this study, we now show that in addition to aortitis, coronary arteritis, and myocarditis, the LCWE-induced KD model also induces the development of abdominal aorta dilatation and AAA, which are exclusively infrarenal, as well as renal and iliac artery aneurysms, mostly in male mice. We also demonstrate the critical pathophysiological role of nucleotide binding domain and leucine-rich repeat pyrin domain containing 3 (NLRP3)-inflammasome-dependent activation of IL-1/IL-1R signaling, and the role of IL-1α and IL-1β in the development of systemic arteritis, abdominal aorta dilatation, and AAA and provide detailed histopathologic data of the aortic vessel wall.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Development of Abdominal Aorta Aneurysms and Dilatation in LCWEInduced KD Vasculitis Mouse Model
We first investigated the development of abdominal aortic dilatation and aneurysms in the LCWE-induced KD mouse model. At 0, 1, 2, 5, and 8 weeks after LCWE injection into male mice, the diameter of abdominal aorta was measured. Over 80% of the mice developed significant dilation of abdominal aorta ( Figure  1A and 1B). LCWE-injected mice showed obvious dilatation and aneurysms exclusively below the right renal artery but not in the suprarenal aorta ( Figure IA and IB in the online-only Data Supplement). We observed localized eccentric dilatation indicative of a saccular aneurysm and a long cylindrical dilatation indicative of a fusiform aneurysm ( Figure IC in the online-only Data Supplement). Aneurysm formation was also detected in the renal and iliac arteries ( Figure 1C) , similar to what is found in patients with KD. 28, 29 These results indicate that LCWE injection induces site-specific vascular remodeling (ie, below the right renal artery). Moreover, magnetic resonance imaging analysis showed that both the lumen and the overall area of abdominal aorta in KD mice significantly increased compared with control mice, indicating that LCWE injection leads to luminal dilatation of abdominal aorta (Figure 1D-1F ; Figure IIA- likely in males compared with females. 7, 10 Male mice showed a significantly greater increase in abdominal aortic diameter compared with female mice (Figure 1G and 1H) . Indeed, female mice did not develop a statistically significant increase in abdominal aortic diameter on LCWE injection.
Abdominal Aorta in KD Mice Show Intense Vessel Wall Inflammation
We next performed a histological analysis of the abdominal aortic lesions. Abdominal aortic tissue was dissected from naive mice and LCWE-injected mice at 14 days. Hematoxylin and eosin and elastin/collagen staining of abdominal aortic sections showed significant intimal proliferation and myofibroblastic proliferation that penetrated and broke the elastin layer with significant inflammatory cell accumulation in media and adventitia ( Figure 2A ). In addition, the AAA lesions showed loss of smooth muscle cells in the media, which is a typical of AAA histology (Figure 2A , bottom). The lesions of iliac and renal arteries also showed similar inflammation ( Figure III in the online-only Data Supplement). We also collected the heart from these same animals to compare the lesion intensity of the coronary and aortic root with the AAA lesions. The intensity of inflammation in the aortic sinus/coronary artery significantly correlated with dilatation of the abdominal aorta ( Figure 2B and 2C), suggesting that heart/coronary lesion progression and AAA were linked.
Innate Inflammatory Cells Infiltrate into the Vessel Wall in Aorta Lesions
To evaluate which types of immune cells are infiltrating into AAA lesions in KD mouse model, AAA sections were stained with antibodies against several cell type-specific markers. We found that large numbers of CD45 + immune cells infiltrated into the adventitia, whereas fewer CD45 + cells were detected in the media and intima of AAA lesions ( 
Correlation of Gene Expression Profiles of Human Adult AAA Disease With That of AAA Seen in the KD Vasculitis Mouse Model
Abdominal aortic lesions in LCWE-induced KD mouse showed the typical histology of human AAA, such as destruction of vascular smooth muscle cell architecture and marked inflammatory cell accumulation (Figures 2 and 3) . To investigate the relevance of the mouse KD AAA lesions to the human (non-KD) AAA that is seen in adults, we evaluated the gene expression profile changes in abdominal aortic lesions of LCWE-injected mice compared with naive mice, and then compared these data with the gene expression changes between the aortas of healthy donors and patients with AAA. 46 We found upregulation or downregulation of 6046 genes and 1643 genes in KD mouse model and AAA patient data, respectively. As shown in the heat map of Figure 4A , the gene expression profiles of KD mouse and patients with AAA were remarkably correlated. Intriguingly, gene expression profile in AAA of KD mice showed marked similarity with adult human AAA disease, including increased expression of IL-1β. Among the 1133 genes that are in common, 1024 genes are in the same Intense inflammatory histology in Lactobacillus casei cell-wall extract (LCWE)-induced abdominal aortic aneurysm (AAA). The heart and abdominal aorta tissues were collected 2 weeks after LCWE injection into male mice. A, Abdominal aorta sections of naive mice and LCWE-injected mice were stained with hematoxylin and eosin (H&E), elastin/ collagen staining, and anti-SM22 Ab. Photomicrographs show normal arterial morphology of naive mice, whereas treated mice show aortae with transmural inflammation, neointimal hyperplasia, medial loss of smooth muscle cells, and fragmentation of medial elastic fibers. B, The heart and abdominal aorta of naive and LCWE-injected mice were stained with H&E. C, The maximal aorta diameter was compared with inflammation score in heart vessels for each mouse. Data were analyzed by Spearman rank correlation test. The scale bar indicates 200 μm (left) and 50 μm (right; A), 500 μm for heart and 200 μm for aorta (B).
orientation of change (579 upregulated and 445 downregulated genes) between KD mouse and patients with AAA, with the genes of top-fold changes indicated ( Figure 4B ). The upregulated genes included inflammatory cytokine IL-1β and some chemokines, which lead to accumulation of immune cells and inflammatory responses. In addition, the gene expression level of matrix metalloproteinase 12 (MMP12), also known as macrophage elastase, was increased 270× in KD mouse AAA lesion compared with control normal mouse abdominal aorta ( Figure 4B ). Consistently, most of the correlations between human adult AAA disease and mouse KD vasculitis-associated AAA involved immune pathways ( Figure 4C ).
IL-1 Signaling and the NLRP3 Inflammasome Are Required for LCWE-Induced Aortic Dilation and Aneurysm Formation in the KD Vasculitis Mouse Model
Among the commonly upregulated genes in human and mouse, AAA lesions were IL-1-related genes. We previously reported the important role of IL-1β in heart vessel inflammation in KD mouse model. 25 To investigate the potential role for IL-1/IL-1R signaling in LCWE-induced abdominal aorta dilation/aneurysm, we injected LCWE into wild-type and Il1r −/− mice. Similar to LCWE-induced KD coronary lesions, Il1r −/− mice were completely protected from AAA development ( Figure 5A and 5B). Both IL-1α and IL-1β bind to same IL-1R, and bone marrow-derived macrophages produced both IL-1α and IL-1β in response to LCWE in vitro ( Figure V in the online-only Data Supplement). We then addressed which IL-1 cytokine was important in AAA development in KD mouse model by injecting LCWE into wild-type, Il1α −/− , and Il1β −/− mice. Both Il1α −/− and Il1β −/− mice were completely protected from abdominal aorta dilatation compared with wild-type mice, indicating that both IL-1α and IL-1β play an important nonredundant role in AAA development ( Figure  5A and 5B).
Inflammasome activation of caspase-1 lead to the production of inflammatory cytokines, including both IL-1β and IL-1α, although to a lesser degree for IL-1α. The NLRP3 inflammasome can be activated by many different danger signals and in vitro data indicated that LCWE activated the inflammasome in macrophages via this pathway. 25 To investigate the role of NLRP3 inflammasome/caspase-1 pathway in formation of LCWE-induced AAA, Casp1 −/− and Nlrp3 −/− mice were injected with LCWE and AAA development was monitored. Both Casp1 −/− and Nlrp3 −/− mice were significantly protected from AAA formation in LCWE-injected mice ( Figure 5C and 5D) . However, the Aim2 inflammasome, which detects intracellular DNA, was not involved in LCWEinduced AAA formation ( Figure 5C and 5D ).
CD11c
+ Macrophages in LCWE-Induced AAA Lesions Have Caspase-1 Activity and Are Critical for AAA Formation in the KD Mouse Model Macrophages, as well as neutrophils are well known producers of IL-1β. Our data indicated large numbers of both these cell types in AAA lesions. To determine which of these cells could be producing IL-1 at the lesions, we visualized caspase-1 activity in the lesions using the fluorescent-labeled inhibitor of caspases assay. Caspase-1 activity was readily detectable at the lesion site, with no activity seen in naive animals ( Figure  6A ). Further investigation found that caspase-1 activity was confined to CD11c + F4/80 + macrophages ( Figure 6B) , with no caspase-1 activity found in Ly6G + neutrophils. Because IL-1 and NLRP3 inflammasome were critical for LCWE-induced AAA formation, and this activity was confined to macrophages at the lesion site, we next depleted macrophages using clodronate liposomes (clodrosomes). Mice given clodrosomes were completely protected from AAA and dilatation ( Figure 6C and 6D), suggesting that macrophages were a key player in AAA development, potentially through their production of IL-1.
Pharmacological Blockade of IL-1/IL-1R Signaling Inhibits AAA Formation in KD Vasculitis Mouse Model
We had previously found that IL-1R antagonist (Anakinra) could inhibit LCWE-induced coronary lesions and myocarditis. 25 To investigate whether Anakinra could also inhibit AAA formation in the KD mouse model, we injected Anakinra into LCWEinjected KD mouse. Anakinra-treated mice showed a significant reduction of maximal aorta diameter and inflammatory histology compared with control mice (Figure 7A and 7B). As a second strategy for treatment, we used neutralizing antibody against either IL-1α or IL-1β to block IL-1 function in vivo. Consistent with the results in gene-deficient mice, both anti-IL-1α and anti-IL-1β mAb administration completely protected the mice from AAA formation after LCWE injection ( Figure 7C-7F) .
Discussion
This study demonstrates that the LCWE-induced KD vasculitis mouse model not only exhibits coronary arteritis, aortitis, myocarditis, but it can also trigger robust systemic artery inflammation involving the abdominal aorta, iliac, and renal arteries, with dilatation and aneurysms (AAA), myofibroblast proliferation, disruption of smooth muscle cell architecture, and massive accumulation of immune cells, which are all hallmark of human KD as well as human AAA histology. Both IL-1α and IL-1β played a key role in the formation of the abdominal aorta dilation and AAA. Notably, inhibition of the inflammasome and IL-1/IL-1R signaling cascade by gene deletion or pharmacological blockade inhibited AAA formation in the KD vasculitis mouse model, suggesting a crucial role of inflammasome-related IL-1 activation in abdominal aorta dilatation and AAA development. Although aortography analysis indicated a generally low incidence of systemic artery aneurysms (1.4%) in patients with KD, pathological analysis of autopsy samples of patients with KD showed abnormalities in systemic arteries, including in the abdominal aorta, iliac, and renal arteries with much higher incidence (>75%). 28, 47 Among patients with KD and systemic artery aneurysms, the brachial and internal iliac arteries are most commonly affected. [48] [49] [50] Interestingly, most systemic artery aneurysms reported in patients with KD were symmetrical and multiple. Abdominal aorta aneurysms were detected mostly in infants during the first 8 months of life. 51 Kato et al 47 showed that KD patients with systemic aortic aneurysms also developed multiple giant coronary aneurysms. The outcomes of systemic aortic aneurysms resemble those of coronary artery lesions. 52 Although some aneurysms regress and others persist, larger aneurysms often lead to stenosis. Similar to coronary arteries, the fate of systemic aortic aneurysms also depends on their diameter in the acute stage of the illness, 53, 54 but the progression of localized stenosis is slower in systemic aortic aneurysms than in the coronary arteries. 49 Progression to excessive remodeling and vasculopathies, cardiovascular diseases, and early death among survivors of childhood KD has been reported with increasing frequency. [33] [34] [35] It is now accepted that systemic vascular inflammation in patients with KD may persist beyond the acute stages and lead to increased risks of subsequent cardiovascular diseases.
In this study, by using the LCWE-induced KD vasculitis model, we observed that the intensity of inflammation in coronary arteries correlate with maximal abdominal aorta diameter, dilatation, and formation of AAA. Of interest, a recent study using the Candida albicans extract-induced KD vasculitis mouse model also reported the development of systemic artery lesions in addition to coronary lesions. 55 Together, these observations suggest that in children with KD the incidence of AAA and dilation may be higher than currently appreciated, particularly in infants <1 year of age with severe KD vasculitis and coronary aneurysms. Our findings also demonstrate that blockade of IL-1/IL-1R signaling, by blocking both IL-1α and IL-1β, may be a promising therapeutic target not only for KD coronary arteritis and myocarditis but also for systemic aortic aneurysms, including abdominal aorta dilatation and AAA that maybe associated with severe KD cases.
Although systemic artery abnormalities other than coronary do not always influence outcome in patients with KD, systemic arteritis is frequently associated with intense systemic vasculitis and can cause severe cardiac sequelae. Progression to excessive remodeling and KD vasculopathies, myocardial dysfunctions, and early death among survivors of childhood KD are being reported with increasing frequency. [33] [34] [35] Indeed, recent reports showed progression of systemic arteritis into stenotic lesions in patients with KD, 29 and these coronary artery sequelae have led to ischemic heart disease in young adults. 56 We have previously shown that the caspase-1/IL-1α and IL-1β pathways are important for the development of coronary arteritis and myocarditis in the LCWE-induced KD murine model. 25, 57 In this study, we found that IL-1/IL-1R signaling and both IL-1α and IL-1β are critical for the formation of AAA, suggesting that the development of cardiovascular lesions associated with KD in both coronary artery and systemic arteries, including for AAA, may share a similar pathophysiology through the NLPR3 inflammasome and the IL-1 signaling pathway. The selective activation of caspase-1 in F4/80 + CD11c + macrophages present in AAA lesions of KD mice, suggests that these cells are responsible for IL-1β production. We previously showed that the mechanism by which the NLRP3 inflammasome is activated is through oxidative mitochondrial DNA in macrophages. 58 It is intriguing that another recent study found that mitochondrial oxidative stress in macrophages can also lead to activation of NLRP3 activation and to the development of AAA in the angiotensin II-induced murine aneurysm model. 59 Although the precise mechanism of NLRP3 inflammasome activation in LCWEinduced AAA remains unknown, our findings highlight the importance of IL-1/IL-1R signaling in both coronary arteritis and systemic artery inflammation with AAA formation in this experimental KD vasculitis model. Similar to IL-1β, IL-1α can bind and activate the downstream signaling cascade of IL-1R. However, the role of IL-1α in KD vasculitis and AAA development remains largely unknown. For the first time, we demonstrate that in addition to Il1b, disruption of Il1a or the use of IL-1α neutralizing antibody significantly inhibited LCWE-induced AAA formation, highlighting the critical role played by IL-1α, in addition to IL-1β in AAA formation in this vasculitis model. Indeed, we have also recently shown the nonoverlapping roles for IL-1α and IL-1β in LCWE-induced coronary arteritis lesions. 57 Supporting these experimental findings, serum IL-1α levels are significantly correlated with AAA severity in human patients and surgical endovascular repair decreased the IL-1α levels, 60 further suggesting a role of IL-1α in human AAA formation as well. In this study, Il1b −/− or wild-type mice treated with anti-IL-1β mAb were completely protected from AAA formation. The fact that IL-1α and IL-1β may recruit neutrophils and macrophages, respectively, and regulate the different phases of the inflammatory response support this finding. 61 It is also possible that these isoforms are released sequentially because IL-1α is often thought of as an alarmin and is produced early during acute inflammation, whereas IL-1β is more associated with the chronic phase of inflammation. 62 Only IL-1β mRNA was upregulated in AAA of both human and KD mouse models. The novel observation that IL-1α and IL-1β Of interest, we observed that MMP12 gene expression was significantly increased in LCWE-induced murine AAA lesions compared with control mouse abdominal aorta. MMP12 haplotypes have been implicated in aneurysm formation in patients with KD, 6 and the expression of MMP12 has been reported in human AAA lesions. 63 Indeed, a recent proteomics study suggests that MMP12 is one of the most abundant metalloproteinase in AAA tissue, underscoring its role in the pathology of human AAA. 64 MMP12 deficiency also attenuated AAA development in the CaCl 2 model of mouse AAA as well as in the angiotensin II-induced AAA model. 65, 66 Interestingly tumor necrosis factor-α and IL-1 can synergistically induce MMP12. 67 In addition to degrading extracellular matrix proteins, MMP12 may also promote macrophage recruitment to the vessel wall by activating tumor necrosis factor-α or by modulating levels of proinflammatory cytokines, such as monocyte chemotactic protein-1.
68
Using available online databases, we were able to compare human AAA upregulated and downregulated genes with those from our LCWE-induced AAA mice. Although the number of genes that were upregulated or downregulated and the fold of upregulation were much greater in mice than in humans, this is not surprising as the experimental model is an induced acute phase model with large lesions developing versus human AAA development, which would be expected to have greater variance than a mouse model. Nevertheless, these findings suggest that the pathways involved in LCWEinduced AAA development may share a similar pathogenesis with human AAA disease and that this KD vasculitis mouse model.
The incidence and severity of abdominal aortic dilations are greater in males than females. 69, 70 Male sex has been consistently identified as a nonmodifiable risk factor for AAA. Evaluation of the AAA histology and pathophysiology in the LCWE-KD vasculitis mouse model revealed the following marked similarities with human AAA disease: (1) histological characteristics (smooth muscle cell loss, disruption of elastin layer, and marked inflammatory cell accumulation), (2) predominant susceptibility in male mouse, (3) development of aneurysmal lesions exclusively at infrarenal aorta (below right renal artery), and (4) gene expression profiles. Consistent with our experimental findings, the IL-1β gene expression and protein levels are markedly elevated in human AAA. [71] [72] [73] Johnston et al 74 demonstrated that genetic disruption of IL-1β as well as Anakinra treatment inhibits AAA development and progression in the elastase-induced AAA mouse model. It is intriguing that IL-1 blocking therapies are currently in phase II clinical trials for both children with KD and adults with AAA disease; Anakinra for KD (NCT02179853) and Canakinumab (anti-IL-1β mAb) for AAA disease (NCT02007252).
Finally, the most commonly used experimental model of AAA is a murine model that requires 28 days of continuous infusion of angiotensin II via osmotic minipumps in Apoe −/− or Ldlr −/− mice, and it is also associated with increased male susceptibility. 75 In the angiotensin II model, only 20% to 40% of animals develop AAA, which universally occur in left suprarenal location (unlike the human counterpart where AAA are always located infrarenally). However, the LCWE-induced KD vasculitis model-associated AAA model requires only a single injection of LCWE, has a penetrance of 80% in mice, and produces exclusively infrarenal AAA lesions. Thus, this model may provide some advantages and potentially may be a valuable alternative experimental model to investigate AAA disease, an area that will need to be further investigated.
In summary, we found that the LCWE-induced KD vasculitis mouse model also exhibits robust systemic artery inflammation involving the abdominal aorta, iliac, and renal arteries, with dilatation and aneurysms, in addition to coronary arteritis, aortitis, and myocarditis. We also show inhibition of IL-1α, IL-1β, or IL-1R leads to marked reduction of AAA formation, suggesting that these IL-1-related molecules are potential therapeutic target for KD vasculitis and AAA patients. The LCWE-induced KD vasculitis mouse model may not only be useful in providing novel mechanistic clues and therapeutic approaches for KD but potentially also for AAA disease.
